Cercle, a groundbreaking AI health tech startup, made its debut on Wednesday, Nov. 8, revealing an impressive lineup of global partners and investors, which notably includes Meta's former COO, Sheryl Sandberg.
By transforming unstructured medical data into a standardized format, Cercle paves the way for fertility doctors and researchers to develop personalized treatment plans and drive pharmaceutical innovations.
Cercle's Up-To-Date Approach
Cercle's innovative platform takes medical records and test results, traditionally scattered and unstructured, and transforms them into a coherent format. This organized data empowers clinicians to gain valuable insights, enabling them to tailor their approach to each patient's unique needs.
For example, a woman considering egg freezing can benefit from Cercle's platform, which provides access to anonymized data from similar cases. Physicians can analyze the outcomes of various treatments, so they can come up with a more personalized and effective treatment plan.
Related Article: Google AI Health Chatbot Passes US Medical Licensing Exam
The Vision of Cercle
"That's the founding mission behind Cercle, to personalize and contextualize biomedical and genomics information so women can make better, more informed health decisions," Cercle's CEO and co-founder, Juan Carlos Riveiro talked about the company's mission, per CNBC.
By putting the power of information into the hands of patients and their healthcare providers, the new startup strives to empower women to make well-informed decisions about their health.
Notable Investors and Partners
Cercle's journey to transform women's health is supported by influential investors like Sheryl Sandberg and her husband, Tom Bernthal, who have channeled their investments through their venture fund, Sandberg Bernthal Venture Partners.
Sheryl Sandberg, who left her role as COO of Meta in June 2022, expressed the fund's commitment to "investing, supporting, and scaling alongside great entrepreneurs."
According to HIT Consultant, the startup is also collaborating with Eurofins Genoma, a genetics company, and US Fertility, the nation's largest fertility network supporting over 100 clinics.
Future Expansion in Women's Health
While Cercle's initial focus is on fertility care, the company has ambitious plans to expand its influence within the broader landscape of women's health.
As the startup's innovative platform continues to make waves in fertility care, it is poised to revolutionize various other aspects of women's health, promising a brighter and more informed future for women worldwide.
With so many AI healthcare startups that are coming out, the industry is projected to be more advanced than in previous years.
Incorporating AI with the work of doctors and other healthcare professionals tends to yield faster and more efficient results in the medical field.
Speaking of which, even AI systems can now be used to discover new medicines, per Tech Times. Researchers collaborate with other experts to see the potential remedies for various diseases.
Read Also: Software Company CEO Believes AI Will End Healthcare's Labor-Intensive Paper Chase
